Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

159.93
+2.991.90%
Volume:2.05M
Turnover:326.48M
Market Cap:248.04B
PE:23.94
High:160.30
Open:157.68
Low:157.23
Close:156.94
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.64
T/O Rate:0.14%
Dividend:3.17
Dividend Rate:1.98%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.93
PE(LYR):24.45

Loading ...

AstraZeneca miss ‘clear positive’ for Omeros, says H.C. Wainwright

TIPRANKS
·
Jul 27

Omeros up 11% to $10.89 after AstraZeneca study failure

TIPRANKS
·
Jul 27

AstraZeneca's Sone-Ve Significantly Extends Overall Survival in Late-Stage Gastric Cancer Phase III Trial

Deep News
·
Jul 27

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Oil Prices Fall

MT Newswires Live
·
Jul 27

Sector Update: Healthcare

MT Newswires Live
·
Jul 27

Pipeline Speed Bump Doesn't Shake AstraZeneca's $80 Billion Revenue Ambition

Benzinga Earnings
·
Jul 27

AstraZeneca Sees Potential for AI Beyond Drug Discovery

Dow Jones
·
Jul 27

AstraZeneca Wants to Move at 'Chinese Speed,' CEO Says

Dow Jones
·
Jul 27

Europe Faces Competition for Pharma Investment, AstraZeneca CEO Says

Dow Jones
·
Jul 27

Europe, Japan are Falling Behind on Pharma Innovation, AstraZeneca CEO Says

Dow Jones
·
Jul 27

AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth

Dow Jones
·
Jul 27

Press Release: AstraZeneca Results: H1 and Q2 2026

Dow Jones
·
Jul 27

AstraZeneca ‘on track’ to deliver ambition of $80B in revenue in 2030

TIPRANKS
·
Jul 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 27

Stocks to Watch: CXMT, LVMH, Nvidia, Chevron

Dow Jones
·
Jul 27

Astrazeneca's Ultomiris Misses Primary Goal in Late-Stage Rare-Disease Trial

MT Newswires Live
·
Jul 27

AstraZeneca Reports 'Positive' Phase 3 Results for Sonesitatug Vedotin in Claudin 18.2-Positive Gastric Cancers

MT Newswires Live
·
Jul 27

AstraZeneca Q2 Core Earnings, Revenue Rise

MT Newswires Live
·
Jul 27

AstraZeneca Results Should Allay Investor Fears

Dow Jones
·
Jul 27

AstraZeneca Beats Q2 Earnings Estimates, Focus Shifts to Next-Generation Oncology Drug Pipeline

Stock News
·
Jul 27